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Background:Massive hemorrhages occur in 6%-10% of patients with advanced cancer. Acute carotid blowout syndrome is
the most severe massive hemorrhagic complication in head and neck cancer patients.
Methods: This was a single institute, retrospective, case control study. A total of 45 patients were enrolled in this study.
The predisposing factors, management, and prognosis of acute carotid blowout syndrome were evaluated.
Results: Among the baseline characteristics, the site of the primary tumor (P [ .003), origin of bleeding (P [ .048),
method of intervention (P [ .005), and time to intervention (P [ .006) were signiﬁcantly different factors between
survivor and nonsurvivor patients. After 24 hours of onset, a Glasgow Coma Scale score (P[ .000), the use of inotropic
agents (P [ .007), and neutrophil-to-lymphocyte ratio (P [ .019) were signiﬁcantly predicting factors for outcome.
Multivariate logistic regression analyses revealed bleeding from common carotid artery was an independent factor for
long-term survival (odds ratio, 25.951; 95% conﬁdence interval [CI], 1.373-490.441; P < .030). The median overall
survival of survivors and nonsurvivors were 12.1 (range, 3.7-118.7; 95% CI, 4.33-54.87) and 11.9 (range, 0.7-53.5; 95%
CI, 5.78-25.69) months, respectively (P [ .092).
Conclusions: Early and aggressive intervention is important for the successful management of acute carotid blowout
syndrome. The Glasgow Coma Scale score, the use of inotropic agents, and neutrophil-to-lymphocyte ratio 24 hours after
the onset were predictive factors for patients’ outcomes. Bleeding from common carotid artery is an independent
prognostic factor in multivariate analysis. Long-term survival can be achieved after successful management. (J Vasc Surg
2013;58:1226-35.)Massive hemorrhages occur in approximately 6%-10%
of patients with advanced head and neck cancer (HNC).
These events may result from local vessel damage caused
by direct tumor invasion or from systemic processes such
as intravascular coagulopathy or abnormalities in platelet
function and number.1 Acute catastrophic bleeding leads
to the rapid demise of the patient, and uncontrolled
bleeding can be quite distressing for staff, patients, and
families.2 Therefore, sufﬁcient preparation for both the
medical and psychological aspects of these bleeding events
is important.3 Because of heterogeneous etiology of
bleeding events, the ﬁrst step in management is to identify
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6for controlling acute life-threatening bleeding and late
complications that may inﬂuence the prognosis for overall
survival (OS) should also be evaluated.1
Acute carotid blowout syndrome (ACBS) is one of the
most complex bleeding complications that may occur in
HNC patients. Carotid blowout syndrome (CBS) has
been categorized as threatened, impending, and acute
subtypes deﬁned as different severity of an episode of hemor-
rhage or exposure of a portion of the carotid arterial system,
which frequently occurs in patients with radiation-induced
necrosis, recurrent tumors, wound complications, or phar-
yngocutaneous ﬁstula.4 Threatened CBS means a visible
exposed carotid artery without healthy tissue covered. The
rupture will happen after a period of time. The secondary
type is impending CBS. These patients have a short-lived
acute hemorrhage and resolved either spontaneously or
with simple packing. It is considered that sentinel hemor-
rhages happen from a ruptured vessel with a pseudo-
aneurysm and the leakage combine with intermittently
bleeding. Because there is no real wall with supporting struc-
tural elements around the pseudoaneurysm, complete
rupture is a certainty and may occur at any time. The third
group, deﬁned as ACBS, is an acute profuse hemorrhage,
which is not self-limiting and advanced cardiac life support
(ACLS) is inevitable.4 For clinicians, the most difﬁcult
complication to manage is massive bleeding due to ACBS.
In Taiwan, because of the unique lifestyle factor of betel
nut chewing,5 the incidence of HNC has increased persis-
tently while the age of the patients has decreased.6 These
patients usually have large primary tumors because of this
habit, which possibly increases the risk of ACBS.7 The
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is therefore an important issue.
For patients who are successfully treated for ACBS,
aggressive resuscitation may be the key. However, the
respective mortality and major neurologic morbidity rates
of ACBS are 40% and 60%,4,8 respectively. ACBS treatment
failure is a major psychological burden for the treating
physicians, the patient, and the patient’s family. In addi-
tion, the late complications that occurs following aggressive
resuscitation decrease the quality of life and eventually the
OS of the affected patients.3 Because ACBS is a suffering
event for patients and their families, understanding the
prognosis and outcome is important for clinics. Therefore,
we sought to identify the predisposing factors, effective
management strategies, and prognostic factors for ACBS.
The results of this study will aid in improving the outcome
of patients with the speciﬁc complication of massive tumor
bleeding.
METHODS
Study design, setting, and patient selection. The
present study was a single institution, retrospective, case
control study. It was reviewed and approved by the Institu-
tional Review Board of Taipei Veterans General Hospital
(No. 2012-07-034BC).
ACBS was deﬁned as acute, profuse hemorrhage that
was not self-limiting over the carotid trunk4 or bleeding
episodes in which ACLS was necessary. Patients were
enrolled between January 1, 2001 and December 31,
2011 according to the imaging and operation records.
Because this was a retrospective study, patient selection
was performed according to medical records. However,
the terms, including tumor bleeding, carotid blowout, oral
bleeding, or neck wound bleeding were described as massive
bleeding in the medical history charts. For the purpose of
identifying the true ACBS cases, only patients with images
conﬁrmed by neck computed tomography (CT)/CT angi-
ography (CTA), invasive carotid angiography, or positive
operation ﬁndings were enrolled. Those diagnosed with
CBS without ACLS, and imaging/operation ﬁndings were
excluded.
Successful management of ACBS was deﬁned as
survival of the patient after an episode of ACBS longer
than 72 hours. Those who survived for less than 72 hours
were classiﬁed as the nonsurvivor group. Because the pres-
ence and persistence of acute circulatory failure in patients
with shock is recognized to be a poor prognostic indica-
tion, and resolution of shock in survivors usually occurs
within the ﬁrst 72 hours,9 early resolution of shock in
such patients might be associated with improved outcomes.
Several large prospective randomized studies also use
a duration of 72 hours as a successful end point for patients
treated with acute shock.10,11 Therefore, we divided
patients with or without survival after an acute episode
according to patients who did or did not survive longer
than 72 hours.
Basic demographic data were recorded, including age,
sex, and initial presentation of the primary tumor (eg,tumor site, staging, pathologic type, preventive therapy
for ACBS, and local recurrence before ACBS). The
descriptions of the bleeding (eg, origin, left or right side,
intra- or extra-oral, and cause of bleeding), and the
managements at the onset of ACBS were also collected.
Management of ACBS. During the onset, ACLS was
performed ﬁrst. Protection of the airwaywith oral intubation
or tracheotomy was also included if necessary. Restoration
of circulating volume was achieved initially by rapid ﬂuid
infusion through large-bore peripheral cannulae. Direct
compression of the bleeding source with epinephrine
packing was performed on all patients. Inotropic agents
were administered to the patients if they had persistent shock
status (systolic blood pressure <90 mm Hg or diastolic
blood pressure <60 mm Hg) without improvement after
massive ﬂuid challenge. At our institution, at least one
interventional neuroradiologist or cardiovascular surgeon
was available within 30 minutes.12 For patients with ACBS,
emergent endovascular treatment or surgical ligation, which
was the procedure immediately at the time of ACBS onset,
was done to reduce the blood loss. For patients without
ACBS, selective endovascular treatment was also arranged to
prevent an unexpected rupture.4 Critical care in the inten-
sive care unit and inotropic agent use were implemented
according to the condition of the patients and the clinicians’
evaluations. The best supportive care was deﬁned as patients
that excluded emergent endovascular treatment or surgical
ligation. Other aggressive treatments according to clinical
conditions, such as ﬂuid hydration, inotropic agents, blood
transfusion, and ACLS were still administered.
Outcome evaluation. The Glasgow Coma Scale score
was evaluated every 4 hours. The complications were
recorded according to whether they occurred in the acute
or delayed time frame. Acute complications were deﬁned
as those that occurred within 72 hours of the onset of
ACBS, and those that occurred more than 72 hours after
the onset of ACBS were considered as delayed complica-
tions. The neutrophil-to-lymphocyte (N/L) ratio differ-
ences, which indicate the severity of clinical physiological
stress,13,14 were also recorded before and 24 hours after
ACBS onset.
To understand the inﬂuence of ACBS to the long-term
survival of HNC, OSs were analyzed for survivors and non-
survivors. OS was calculated from the date of disease
diagnosis to the date of death by any cause, or the date
on which the patient was last evaluated.
Statistical analysis. Categorical variableswere compared
using the c2 and Fisher exact tests. The Mann-Whitney
test was used for continuous variables. The independent
factors of surviving longer than 72 hours were analyzed
with univariate and multivariate logistic regressions. We
used logistic regression to analyze the risk factors for survival
because the end point of univariate and multivariate analysis
was to predict survival or not after ACBS rather than
the impact of ACBS for survival duration. The factors with
P value of <.05 in univariate analyses were included in
multivariate logistic regressions. OS was analyzed using
the log-rank test and expressed as Kaplan-Meier plots.
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All statistical analysis was performed using SPSS statistical
software v. 18.0 (SPSS Inc, Chicago, Ill).
RESULTS
Baseline characteristics between survivor and
nonsurvivor patients. Between January 1, 2001 and
December 31, 2011, there were 3504 patients with newly
diagnosed HNC in our institution. One hundred and three
patients (103/3504, 2.9%) who suffered from CBS were
identiﬁed by imaging/operation ﬁnding. They included
threatened, impending, and acute subtypes of CBS based
on the study by Chaloupka et al.4 Among these, only 45
patients with ACBS, which included acute and profuse
hemorrhage without self-limiting over the carotid trunk and
immediately emergent treatments where necessary, were
enrolled in the present study to analyze the predisposing
factors, management, and prognosis. Thirty-four patients
(34/45, 75.6%) were treated successfully after aggressive
management, whereas 11 patients were treated unsuccess-
fully. Other patients without ACBS and who accepted
preventive or scheduled therapies have been analyzed in our
previous study.15
Basic characteristics of both survivor and nonsurvivor
patients are presented in Table I. Nearly one-half of
patients (19/45, 42.2%) were younger than 50 years old
and 91.1% of patients (41/45) were male. Squamous cell
carcinoma was the most common pathologic type (38/
45, 84.4%). There were signiﬁcant differences between
the two groups in tumor site (P ¼ .003), origin of bleeding
(P ¼ .048), method of intervention (P ¼ .005), and time
to intervention (P ¼ .006).
The longest time to intervention of those ACBS
patients with invasive procedures was 49 hours. Because
there were eight patients who refused any invasive treat-
ments and the time to intervention would be inﬁnite for
them, we recorded these cases as up to 60 hours to represent
the longest time to intervention. The median times to inter-
vention for both groups were 3.3 hours (0.4-60.0) and 60.0
hours (1.5-60.0), respectively. The survivor patients had
a signiﬁcantly shorter time to intervention than nonsurvivor
patients (P ¼ .003). Other factors such as aggressive hydra-
tion, intensive critical care, and blood component support
were similar (Table I).
Angiography resulted in more precise diagnosis of
ACBS bleeding site than computed tomography. Fig 1
shows two cases of successful ACBS treatment. A 54-year-
old man who was diagnosed with hypopharyngeal cancer
had ACBS (Fig 1, A and B). This patient was under
palliative chemotherapy because of recurrent disease. The
CT scan revealed necrotic soft tissue involving the retro-
pharyngeal region (Fig 1, A). The angiography examina-
tion revealed acute extravasation from a pseudoaneurysm
of the left middle common carotid artery (CCA) (Fig 1, B).
After aggressive management, this patient survived for 7
months from the time of onset. The second case (Fig 1, C
and D) involved a 67-year-old man who was diagnosed
with glottic cancer and admitted because of poor woundhealing after neck dissection. The CT scan showed a deep
ulcerative wound that was close to the right CCA in the
right anterior neck (Fig 1, C). The lesion that was present
in the right CCA is shown in Fig 1, D. After emergent
endovascular treatment, the patient survived and was fol-
lowed in the clinical ward for more than 16 months.
Univariate and multivariate logistic regression
analysis for prognostic factor of ACBS. Univariate anal-
yses of survivor patients also revealed that primary tumor
site (oropharynx, P ¼ .006; hypopharynx, P ¼ .048), the
origin of bleeding (CCA, P ¼ .031), method of intervention
(best supportive care, P ¼ .002), and time to intervention
(>12 hours, P ¼ .020) were signiﬁcant prognostic factors.
Multivariate analyses indicated that bleeding of the CCA
was the only independent factor for survivor patients
(odds ratio, 25.951; 95% conﬁdence interval [CI], 1.373-
490.441; P < .030) (Table II). Because of the small
number of patients enrolled in this study, the characteristics
of ACBS patients were unevenly distributed. Such distribu-
tion pattern resulted in the large range of 95% CI.
Consciousness level, the use of inotropic agents,
and N/L ratio change are important predictors for the
outcomes of ACBS. Under aggressive treatment, the inci-
dence of acute complications was similar in both groups.
Aspiration pneumonia and stroke/transient ischemic attack
were the most common complications. More patients in
the survivor group had a better consciousness level (Glas-
gow coma score $9) than patients in the nonsurvivor
group 24 hours after ACBS onset (P ¼ .000; Table III).
Inotropic agent used 24 hours after ACBS was signiﬁcantly
higher in nonsurvivor patients (P ¼ .007). The hemo-
globin concentration was recorded to evaluate the hemo-
dynamic status of the patients, which did not differ
between the two groups. Because the N/L ratio reﬂects
the level of severe physiological stressors such as massive
bleeding or critical condition,13-17 the baseline and
24-hour N/L ratios were assessed. There were similar N/L
ratios between the groups at the onset of ACBS (P ¼
.605); however, both groups had a higher N/L ratio than
the baseline 24 hours after onset (P ¼ .019 and .012;
Fig 2). The N/L ratio 24 hours after onset was higher in
the nonsurvivor group compared with the survivor group
(P ¼ .007; Table III; Fig 2).
Outcomes of the various treatment modalities.
Except eight patients without aggressively invasive treat-
ment, there were 30 patients who received endovascular
therapy and seven patients received surgical treatment.
Patients would receive surgical ligation if radical neck
dissection was done recently without the wound healing
completely. The most frequent etiology of bleeding after
radical neck dissection was tumor involvement (4/7;
57.1%). Others included ﬁstula formation (1/7; 14.3%),
local inﬂammation/necrosis (1/7; 14.3%), and postopera-
tion complication (1/7; 14.3%).
Surgical treatment showed a higher mortality rate than
endovascular therapy. Mortality rate of best supportive
care, endovascular therapy, and surgical ligation were
75% (6/8), 10% (3/30), and 28.6% (2/7), respectively.
Table I. Basic characteristics of patients with ACBS
Characteristics
Survivor
patients
(n ¼ 34)
Nonsurvivor
patients
(n ¼ 11)
P
value
Age, years .273
$50 21 (61.8%) 5 (45.5%)
<50 13 (38.2%) 6 (54.5%)
Sex .311
Male 30 (88.2%) 11 (100.0%)
Female 4 (11.8%) 0 (0.0%)
Tumor site .003
Oral cavity 8 (23.5%) 0 (0.0%)
Nasopharynx 2 (5.9%) 2 (18.2%)
Oropharynx 4 (11.8%) 6 (54.5%)
Hypopharynx 16 (47.1%) 1 (9.1%)
Larynx 1 (2.9%) 2 (18.2%)
Othersa 3 (8.8%) 0 (0.0%)
Initial T stage .520
#T2 9 (26.5%) 4 (36.4%)
>T2 24 (70.6%) 6 (54.5%)
Unknownb 1 (2.9%) 1 (9.1%)
Initial N stage .141
N0 6 (17.6%) 5 (45.5%)
Nþ 26 (76.5%) 5 (45.5%)
Unknownb 2 (5.9%) 1 (9.1%)
Initial M stage .422
M0 31 (91.2%) 11 (100.0%)
M1 3 (8.8%) 0 (0.0%)
Pathologic type .207
Squamous cell carcinoma 30 (88.2%) 8 (72.7%)
Adenosquamous carcinoma 1 (2.9%) 0 (0.0%)
Nonkeratinizing carcinoma 1 (2.9%) 2 (18.2%)
Leiomyosarcoma 1 (2.9%) 0 (0.0%)
Carcinoma, undifferentiated 1 (2.9%) 1 (9.1%)
Prevent therapy for ACBS .341
None 28 (82.4%) 9 (81.8%)
Stent insertion 0 (0.0%) 1 (9.1%)
Embolization 2 (5.9%) 1 (9.1%)
Stent insertion and
embolization
2 (5.9%) 0 (0.0%)
Surgical procedure 2 (5.9%) 0 (0.0%)
Local recurrence before ACBS .325
Yes 20 (58.8%) 8 (72.7%)
No 14 (41.2%) 3 (27.3%)
Origin of bleeding .048
ICA 5 (14.7%) 0 (0.0%)
ECA or its branches 16 (47.1%) 2 (18.2%)
CCA 7 (20.6%) 5 (45.5%)
Carotid bifurcation 4 (11.8%) 1 (9.1%)
Combinationc 1 (2.9%) 0 (0.0%)
Unknownd 1 (2.9%) 3 (27.3%)
Side of ACBS .466
Left 18 (52.9%) 5 (45.5%)
Right 16 (47.1%) 6 (54.5%)
Site of bleeding .390
Intraoral 21 (61.8%) 8 (72.7%)
Extraoral 13 (38.2%) 3 (27.3%)
Cause of bleeding .522
Tumor relatede 13 (38.2%) 7 (63.6%)
Pseudoaneurysm 15 (44.1%) 3 (27.3%)
Soft tissue inﬂammation 3 (8.8%) 0 (0.0%)
Fistula formation 2 (5.9%) 1 (9.1%)
Postoperative complication 1 (2.9%) 0 (0.0%)
Method of intervention .005
Best supportive care 2 (5.9%) 6 (54.5%)
Stent insertion 3 (8.8%) 0 (0.0%)
Embolization 20 (58.8%) 3 (27.3%)
Table I. Continued.
Characteristics
Survivor
patients
(n ¼ 34)
Nonsurvivor
patients
(n ¼ 11)
P
value
Stent insertion and
embolization
4 (11.8%) 0 (0.0%)
Surgical procedure 5 (14.7%) 2 (18.2%)
Time to intervention, hours .006
#3 15 (44.1%) 1 (9.1%)
>3 and #6 7 (20.6%) 2 (18.2%)
>6 and #12 4 (11.8%) 1 (9.1%)
>12 6 (17.6%) 1 (9.1%)
Patients refuse 2 (5.9%) 6 (54.5%)
Total ﬂuid challenge
in the ﬁrst 24 hours, L
.667
#2 1 (4.2%) 0 (0.0%)
>2 and #3 5 (20.8%) 3 (42.9%)
>3 and #4 4 (16.7%) 1 (14.3%)
>4 14 (58.3%) 3 (42.9%)
No. of patients available 24 7
Total ﬂuid output in the
ﬁrst 24 hours, L
.188
#2 9 (37.5%) 3 (42.9%)
>2 and #3 7 (29.2%) 0 (0.0%)
>3 and #4 3 (12.5%) 3 (42.9%)
>4 5 (20.8%) 1 (14.3%)
No. of patients available 24 7
The blood component support
in the ﬁrst 24 hours, U
PRBC 4 (0-28) 4 (4-16) .369
Plt. pheresis 0 (0-4) 0 (0-4) .429
FFP 2 (2-16) 4 (4-14) .387
Intensive critical care 20 (58.8%) 5 (45.5%) .333
ACBS, Acute carotid blowout syndrome; CCA, common carotid artery;
ECA, external carotid artery; ICA, internal carotid artery; FFP, fresh frozen
plasma; Plt, platelet; PRBC, packed red blood cells.
aOthers: carcinoma of unknown primary, nasal antrum, and ethmoid sinus
cancer.
bUnknown cases were diagnosed at another hospital without initial data.
cThe origins of bleeding involved left ICA, lingular artery and superior
thyroid arteries.
dPatients and their families refused invasive procedures at ACBS onset.
eIncluding tumor necrosis or tumors involving the vessels.
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number of patients was too small in each treatment group,
the modalities were hard to compare with each other. For
patients who received embolization and surgical ligation,
the most frequent complication was aspiration pneumonia
(14/23, 60.9% for embolization; 3/7, 42.9% for surgical
ligation). Delayed stroke/transient ischemic attack was
the main problem of patients with stent insertion (1/3,
33.3%). Recurrent CBS treated with endovascular therapy
and surgical ligation were 20% (6/30) and 0% (0/7),
respectively.
Long-term survival of patients after successful
management of ACBS. To understand the inﬂuence of
ACBS on the disease course, Kaplan-Meier analyses were
used to evaluate the long-term survival trends. The
median overall survival of survivors and nonsurvivors were
12.1 (range, 3.7-118.7; 95% CI, 4.33-54.87) and 11.9
(range, 0.7-53.5; 95% CI, 5.78-25.69) months, respec-
tively (P ¼ .092) (Fig 3).
Fig 1. Computed tomography (CT) and angiography ﬁndings of acute carotid blowout syndrome (ACBS). In (A) and
(B), a 54-year-old man who was diagnosed with hypopharyngeal cancer and under palliative chemotherapy treatment
presented with acute left common carotid artery (CCA) CBS. A CT scan revealed necrotic soft tissue involving the left
CCA (thick black arrow). The angiography results revealed acute extravasation from a pseudoaneurysm of the left
middle CCA (thick white arrow). In (C) and (D), a 67-year-old man with glottic cancer was evaluated for poor wound
healing following neck dissection. A deep ulcerative wound was found in the right anterior neck. The lesion was close to
the right CCA (thin black arrow). Acute rupture in the right CCA was found on angiography (thin white arrow).
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ACBS, usually a life-threatening complication of HNC,
is accompanied with unexpectedly massive bleeding and
high mortality/morbidity rates.4,8 In this study, location
of primary tumor and bleeding sites, as well as early and
aggressive interventions persistently showed importance
for survivor patients. The changes in the consciousness level,
inotropic agent usage, andN/L ratio after 24 hours were the
major factors that were predictive of ACBS outcomes.
Multivariate analysis showed that CCA bleeding was the
signiﬁcantly prognostic factor for long-term survival.
Surgical ligation and endovascular therapy are the main
treatments for CBS patients. Surgical management was the
ﬁrst option for CBS patients traditionally.18 Because ACBS
was an early complication following radical neck dissection,
some patients would receive surgical ligation if radical neck
dissection was done recently without the wound healing
completely.18,19 Raising skin ﬂaps in the neck was quick
and easy to expose deep cervical fascia and to check
bleeding, this procedure was also the emergent method
to stop bleeding. After removing skin ﬂaps, deep cervical
fascia and carotid sheath, which coated internal jugular
vein, vagus nerve, and carotid artery, were dissected. Afteridentifying the source of bleeding, the rupture site was
repaired, and the carotid artery was ligated. If the border
of the artery or other vital organs could not be divided
clearly because of severe ﬁbrosis, we would keep ﬁnding
carotid artery through the pulsation. Then, the CCA and
the furcation area could be reached. Debridement was
also done if necrotic tissue was found. The operative
wound was irrigated with beta-iodine and normal saline
to minimize the contamination. Then, the wound was
closed with Vicryl and nylon. After completing the proce-
dure, patients were sent to the intensive care unit for post-
operative care. However, open surgical techniques were
gradually replaced with endovascular therapy because of
high mortality/morbidity after surgical ligation.18,20 In
addition, direct exploration and repair of the previously
irradiated ﬁeld were also difﬁcult for surgeons to
approach.19 Therefore, endovascular therapy, including
destructive (embolization) and constructive (stent grafting)
techniques, are gaining popularity for the treatment of
ACBS recently. More and more articles have discussed
the effect and outcomes of endovascular therapy.19,20
The morbidity/mortality rates are signiﬁcantly decreased
in endovascular therapy than in surgical treatment.20,21
Table II. Univariate and multivariate logistic regression analysis for the prognostic factor of ACBS
Variable
Univariate
Multivariate
P value P value OR (95% CI)
Age, $50 years .345
Male .999
Tumor site
Oral cavity .999
Nasopharynx .235
Oropharynx .006 .229 5.369 (0.347-83.090)
Hypopharynx .048 .099 0.056 (0.002-1.717)
Larynx .120
Pathological type
Squamous cell carcinoma .230
Adenosquamous carcinoma 1.000
Nonkeratinizing carcinoma .120
Leiomyosarcoma 1.000
Carcinoma, undifferentiated .413
Prevent therapy for ACBS .968
Treatment just before ACBS
Palliative chemotherapy .243
Concurrent chemoradiotherapy .999
None .433
Origin of bleeding
ICA .999
ECA or its branches .242
CCA .031 .030 25.951 (1.373-490.441)
Carotid bifurcation .977
Combinationa 1.000
Cause of bleeding
Tumor relatedb .149
Pseudoaneurysm .327
Soft tissue inﬂammation .999
Fistula formation .713
Postoperative complication 1.000
Method of intervention
Best supportive care .002 .394 4.759 (0.132-171.649)
Stent insertion .999
Embolization .079
Stent insertion and embolization .999
Surgical procedure .783
Time to intervention, hours
#3 .061
>3 and #6 .862
>6 and #12 .807
>12 .020 .783 1.494 (0.086-25.981)
Local recurrence before ACBS .412
ACBS, Acute carotid blowout syndrome; CCA, common carotid artery; CI, conﬁdence interval; ECA, external carotid artery; ICA, internal carotid artery;
OR, odds ratio.
aThe origins of bleeding involved left ICA, lingular artery, and superior thyroid arteries.
bIncluding tumor necrosis or tumors involving the vessels.
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including deconstructive and constructive. However, there
were limited data that compare the outcomes between
deconstructive and constructive treatments for patients
with ACBS.20 Current evidence shows that there was no
signiﬁcant difference in technical and hemostatic outcomes
between the reconstructive and deconstructive endovascu-
lar methods19-21 because permanent vessel occlusion
resulted in higher immediately cerebral ischemia and
stent grafting induced the more potentially delayed compli-
cations, such as infection, rebleeding, and stent throm-
bosis.18,20 In our practice, patients whose pathologiclesions involved the branches of external carotid artery
were only administered with deconstructive manage-
ment.19 Those involving the main trunk of the carotid
artery received either deconstructive treatment or construc-
tive treatment according to the result of a balloon occlu-
sion test (BTO), which evaluates blood supply from
intracranial collateral circulation.22 Stent grafting was
considered if the circle of Willis was incomplete, or an
unstable clinical condition precluded BTO. Because stent
grafts have to be self-paid by patients in Taiwan, the cost
effectiveness should also be explained. Stent grafting was
also suggested if the areas of pathologic involvement
Table III. Outcome characteristics of patients with ACBS
Variable
Survivor patients
(n ¼ 34)
Nonsurvivor patients
(n ¼ 11) P value
Glasgow coma score after 24 hours .000
$9 29 (73.5%) 0 (0.0%)
6-8 2 (5.9%) 3 (27.3%)
#5 4 (11.8%) 6 (54.5%)
Unknown 3 (8.8%) 2 (18.2%)
Inotropic agent use 24 hours after ACBS 11 (32.4%) 7 (87.5%) .007
No. of patients evaluated 34 8
Acute complicationsa
Stroke/TIA 3 (8.8%) 0 (0.0%) .422
Aspiration pneumonia 13 (38.2%) 4 (36.4%) .602
Femoral hematoma 1 (2.9%) 0 (0.0%) .756
Delayed complicationsa
Stroke/TIA 2 (5.9%) NA NA
Aspiration pneumonia 4 (11.8%) NA NA
Brain abscess 1 (2.9%) NA NA
Wound infection 2 (5.9%) NA NA
Empyema 1 (2.9%) NA NA
Femoral hematoma 1 (2.9%) NA NA
Upper gastrointestinal bleeding due to antiplatelet agents 2 (5.9%) NA NA
Serum markers 24 hours after ACBS onset
Complete blood count
WBC (103 cells/mL) >10.0 19 (63.3%) 7 (100%) .064
Hgb (g/dL) <11.0 5 (16.7%) 3 (42.9%) .156
PLT (103 cells/mL) >400.0 1 (3.3%) 1 (14.3%) .347
No. of patients evaluated 30 7
Differential count
N/L ratio 20.7 (5.9-48.5) 48.5 (10.5-93.0) .007
Monocyte (cells/mL) >1000 10 (35.7%) 3 (42.9%) .525
No. of patients evaluated 28 7
ACBS, Acute carotid blowout syndrome; Hgb, hemoglobin; NA, not analyzed; N/L, neutrophil-to-lymphocyte; PLT, platelet count; TIA, transient ischemic
attack; WBC, white blood cell.
aAcute complications were deﬁned as complications that occurred within 72 hours after massive bleeding; delayed complications were deﬁned as those that
occurred after more than 72 hours.
JOURNAL OF VASCULAR SURGERY
1232 Lu et al November 2013were too large to be embolized, so that embolizing to the
external carotid artery or its branches and keeping the
blood supply from CCA to the internal carotid artery
(ICA) with stent grafting were considered. There are
some reasons that permanent vessel occlusion remains the
standard therapy for ACBS patients in our institution. First,
because delayed complications and long-term outcomes are
unclear with stent grafting,18,20 constructive treatment has
to be self-paid by patients in Taiwan and the cost effective-
ness of stent grafting should be evaluated. Second, whether
the ability of stopping bleeding is comparable in stent graft-
ing is still controversial.15,22,23 So, the constructive treat-
ment was only applied for patients with the incomplete
circle of Willis, precluding an occlusion test, or intolerant
BTO, that when carotid occlusion poses an unusually
high risk of neurologic morbidity.24
Initial resuscitation in a minimal amount of time and
identiﬁcation of the source of bleeding with immediate
intervention are critical for the management of massive
bleeding events.25 These management strategies result in
successful patient survival and hemostasis.19 At our institu-
tion, interventional teams were available within 30 minutes
after they were informed about a massive bleeding event.
Other multidisciplinary teams were also placed on all-daystandby.12 Therefore, at the onset of ACBS, ACLS was
provided immediately in accordance with the patients’
needs, and invasive interventions were prepared well in
advance. Blood component support and critical care after
these interventions were more readily available at our
hospital compared with other local medical institutions.
With multidisciplinary cooperation, we were able to
provide a high level of medical care for all patients with
ACBS and achieved a good success rate.
The primary tumor site and origin of bleeding signiﬁ-
cantly inﬂuenced the patient outcomes. In a previous
study, the luminal vessel diameter impacted the outcome
of ACBS, as it is relatively difﬁcult to perform interventions
and control hemostasis in vessels with large luminal diam-
eters.26 Moreover, patients with ICA or CCA involvement
are more likely to experience immediate/delayed cerebral
ischemia and more blood loss,24 which leads to high
mortality/morbidity rates. Another possible explanation is
that a primary tumor that is located far from the ICA or
CCA is less likely to directly involve these arteries, which
also results in better survival outcomes.
ACBS is a rare and rapidly progressive complication.
ACBS patients always suffer from loss of consciousness,
cardiac arrest, or hypovolemic shock; ACLS is needed at
Fig 2. Neutrophil-to-lymphocyte (N/L) ratio before and after
acute carotid blowout syndrome (ACBS) in survivor or non-
survivor patients. The N/L ratios were signiﬁcantly higher 24
hours after ACBS onset relative to those at initial onset (P ¼ .012
and .019 in both groups, respectively). The N/L ratio did not
differ between both groups at initial onset (P ¼ .527), but was
signiﬁcantly much higher in the group with nonsurvivors than in
the group with survivors after 24 hours (P ¼ .007).
Fig 3. Overall survival of survivors and nonsurvivors. The median
overall length of survival of survivors and nonsurvivors was 12.1
(range, 3.7-118.7; 95% conﬁdence interval [CI], 4.33-54.87) and
11.9 (range, 0.7-53.5; 95% CI, 5.78-25.69) months, respectively
(P ¼ .092).
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difﬁculty to manage, patients may expire in a very short
period of time without enough follow-up. Hemodynamic
status is an important factor that is capable of predicting
the outcome of massive bleeding because it results in pro-
longed hypovolemic shock and severe vasoconstriction.
This condition also induces multiorgan failure and tissue
ischemia.25,27 However, it is difﬁcult to evaluate hemody-
namic status using blood pressure measurements and the
volume of blood transfused in practice, as vessel constric-
tion and the use of inotropic agents might mask the real
hemodynamic status. Some articles have proposed the
prognostic factors to evaluate patients with severe shock,
but they were inappropriate for ACBS patients because of
short clinical courses to be followed up.28-34 The use of
N/L ratio is easily assessed, and the data are quickly avail-
able. Therefore, we examined several serum markers that
could reﬂect the severity of systemic inﬂammation and
physiological stress.13,14 Zahorec et al used the N/L ratio
as a parameter for the intensity of stress/systemic inﬂam-
mation in critically ill patients following shock, multiple
trauma, major surgery, or sepsis.13 Physiological stress is re-
ﬂected as systemic inﬂammation,35 which mediates
complex interactions that inﬂuence the N/L ratio.14
Therefore, in patients who have systemic stress/inﬂamma-
tion and local endothelial injury, the N/L ratio indeed
reﬂects the degree of endovascular injury and diseaseseverity.16,17 The results of the current study also suggested
that patients who did not survive had higher levels of phys-
iological stress reﬂected by an increase in the N/L ratio.
In previous studies, the most common cause of
mortality for patients that survived ACBS is disease
progression rather than related complications.12,26 Our
study also showed that the long-term progression-free
survival and OS of ACBS patients were similar to those
of patients without ACBS.36,37 With successful treatment,
long-term survival can be achieved in patients with ACBS.
There were some limitations in this study. The ﬁrst was
the small number of patients and inherent selection bias.
Because this was a retrospective study, patient selection
was performed according to medical records. However,
the terms, including tumor bleeding, carotid blowout,
oral bleeding, or neck wound bleeding, were described as
massive bleeding in the charts. Therefore, it was difﬁcult
to identify the true ACBS cases. In our study, in addition
to massive bleeding, ACBS was identiﬁed according to
CT/CTA, invasive carotid angiography, or operation ﬁnd-
ings. Patients who were diagnosed with bleeding without
CT/CTA, invasive carotid angiography, or operation ﬁnd-
ings were excluded from the analysis.
In conclusion, aggressive and early interventions are
important for the management of ACBS. Other factors
such as the source of bleeding and N/L ratio changes
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1234 Lu et al November 2013were prognostic factors for patient outcomes. Bleeding
from CCA is an independent prognostic factor. With
successful management, long-term survival rates of these
patients could be achieved that are comparable with
HNC patients without ACBS.
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